What does fact checked mean?
At Healthfully, we strive to deliver objective content that is accurate and up-to-date. Our team periodically reviews articles in order to ensure content quality. The sources cited below consist of evidence from peer-reviewed journals, prominent medical organizations, academic associations, and government data.
- Mayo Clinic; Nonalcoholic Fatty Liver Disease; February 2011
- "Microvascular Research"; The Role of Nitric Oxide in the Modulation of Hepatic Microcirculation and Tissue Oxygenation in an Experimental Model of Hepatic Steatosis; S. Ijaz et al.; November 2005
- "Microvascular Research"; The Role of Nitric Oxide in the Modulation of Hepatic Microcirculation and Tissue Oxygenation in an Experimental Model of Hepatic Steatosis; S. Ijaz et al.; November 2005
- Mayo Clinic; Arginine Safety; August 2011
The information contained on this site is for informational purposes only, and should not be used as a substitute for the advice of a professional health care provider. Please check with the appropriate physician regarding health questions and concerns. Although we strive to deliver accurate and up-to-date information, no guarantee to that effect is made.
L-Arginine and Fatty Liver Disease
L-arginine is an amino acid that’s made in your body and found in foods such as soybeans, nuts and grains. Its main functions are to convert toxic ammonia to the waste product urea and provide immune system support. L-arginine shows promise in improving fatty liver disease, or hepatic steatosis, by increasing blood flow to the organ. However, further research is needed.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
Fatty Liver Disease
Fatty liver disease refers to either alcoholic fatty liver disease or nonalcoholic fatty liver disease 1. Most cases of fatty liver disease are related to nonalcoholic fatty liver disease, which is the excess buildup of lipids in the liver 1. Although nonalcoholic fatty liver disease often produces no symptoms, a few symptoms have been reported, including fatigue and weight loss 1. Over time, nonalcoholic fatty liver disease can lead to inflammation and scarring of your liver, according to the Mayo Clinic 1.
Risk Factors
Low Platelet Count & Fatty Liver Disease
Learn More
Several factors can increase your risk for nonalcoholic fatty liver disease, including obesity, hypertension, high cholesterol, metabolic syndrome, diabetes and high triglycerides 1.cause:
- Several factors can increase your risk for nonalcoholic fatty liver disease
- including obesity
- hypertension
- high cholesterol
- metabolic syndrome
- diabetes
- high triglycerides 1
Since the disease is often asymptomatic, the best way to test for nonalcoholic fatty liver disease is by taking a blood test or liver tissue test, according to the Mayo Clinic 1.
Liver Blood Flow
People with nonalcoholic fatty liver disease normally have reductions in blood flow to the liver, which inhibits the organ from receiving enough nutrients and oxygen to reverse the condition 1. Scientists at the University College London in the United Kingdom observed that rats with hepatic steatosis taking L-arginine daily for 12 weeks experienced improvements in blood flow to the liver. Researchers stated that L-arginine increases the production of nitric oxide, a gas molecule that boosts blood flow. The findings were reported in the November 2005 issue of "Microvascular Research.” Although these findings are promising, human studies need to be performed.
- People with nonalcoholic fatty liver disease normally have reductions in blood flow to the liver, which inhibits the organ from receiving enough nutrients and oxygen to reverse the condition 1.
- Scientists at the University College London in the United Kingdom observed that rats with hepatic steatosis taking L-arginine daily for 12 weeks experienced improvements in blood flow to the liver.
Side Effects
Low Platelet Count & Fatty Liver Disease
Learn More
Side effects such as gastrointestinal upset, diarrhea, nausea and increased blood sugar levels have been reported in those who take L-arginine supplements. Consult your health care provider before taking any supplements.
Related Articles
References
- Mayo Clinic; Nonalcoholic Fatty Liver Disease; February 2011
- "Microvascular Research"; The Role of Nitric Oxide in the Modulation of Hepatic Microcirculation and Tissue Oxygenation in an Experimental Model of Hepatic Steatosis; S. Ijaz et al.; November 2005
- Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol. 2017;9(16):715–732. doi:10.4254/wjh.v9.i16.715
- Hassan K, Bhalla V, El Regal ME, A-Kader HH. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol. 2014;20(34):12082–12101. doi:10.3748/wjg.v20.i34.12082
- InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006-. How does the liver work? 2009 Sep 17 [Updated 2016 Aug 22].Available from: https://www.ncbi.nlm.nih.gov/books/NBK279393/
- Chan SC, Liu CL, Lo CM, et al. Estimating liver weight of adults by body weight and gender. World J Gastroenterol. 2006;12(14):2217–2222. doi:10.3748/wjg.v12.i4.2217
- Neuman MG, Cohen LB, Nanau RM. Biomarkers in nonalcoholic fatty liver disease. Can J Gastroenterol Hepatol. 2014;28(11):607–618.
- Calzadilla Bertot L, Adams LA. The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016;17(5):774. Published 2016 May 20. doi:10.3390/ijms17050774
- Jennison E, Patel J, Scorletti E, Byrne CD. Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J. 2019;95(1124):314-322.
- Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019;7(4):313-324.
- Jeznach-Steinhagen A, Ostrowska J, Czerwonogrodzka-Senczyna A, Boniecka I, Shahnazaryan U, Kuryłowicz A. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. Medicina (Kaunas). 2019;55(5):166. Published 2019 May 20. doi:10.3390/medicina55050166
- Fatty Liver Disease. Canadian Liver Foundation Public Information Sheet.
- Lazo, et al. “Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study.” BMJ. 2011 Nov 18;343:d6891.
- Non-alcoholic Fatty Liver Disease (NAFLD). American Liver Foundation Public Information Sheet.
- Nonalcoholic Steatohepatitis. US Department of Health and Human Services Public Information Sheet.
- Angulo, Paul, and Lindor, Keith. Non-alcoholic Fatty Liver Disease. Journal of Gastroenterology and Hepatology (2002) 17 (Suppl.) S186–S190.
- Ludwig, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55:434-8.
Writer Bio
Brandon Dotson is a graduate of Lehman college with a Bachelor of Science in health education and a minor in marketing. He has been a writer for over five years and plans on pursuing a master's degree in marketing.